Literature DB >> 14527309

The genetics of narcolepsy.

Dorothee Chabas1, Shahrad Taheri, Corinne Renier, Emmanuel Mignot.   

Abstract

Human narcolepsy is a genetically complex disorder. Family studies indicate a 20-40 times increased risk of narcolepsy in first-degree relatives and twin studies suggest that nongenetic factors also play a role. The tight association between narcolepsy-cataplexy and the HLA allele DQB1*0602 suggests that narcolepsy has an autoimmune etiology. In recent years, extensive genetic studies in animals, using positional cloning in dogs and gene knockouts in mice, have identified abnormalities in hypothalamic hypocretin (orexin) neurotransmission as key to narcolepsy pathophysiology. Though most patients with narcolepsy-cataplexy are hypocretin deficient, mutations or polymorphisms in hypocretin-related genes are extremely rare. It is anticipated that susceptibility genes that are independent of HLA and impinge on the hypocretin neurotransmitter system are isolated in human narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527309     DOI: 10.1146/annurev.genom.4.070802.110432

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  31 in total

1.  Modafinil in sports: ethical considerations.

Authors:  K R Kaufman
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

2.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

Review 3.  Man's best friend becomes biology's best in show: genome analyses in the domestic dog.

Authors:  Heidi G Parker; Abigail L Shearin; Elaine A Ostrander
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

Review 4.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

5.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 6.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

7.  Genomewide association analysis of human narcolepsy and a new resistance gene.

Authors:  Minae Kawashima; Gen Tamiya; Akira Oka; Hirohiko Hohjoh; Takeo Juji; Takashi Ebisawa; Yutaka Honda; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Am J Hum Genet       Date:  2006-06-13       Impact factor: 11.025

8.  Analysis of cortical thickness in narcolepsy patients with cataplexy.

Authors:  Eun Yeon Joo; Seun Jeon; Minjoo Lee; Sung Tae Kim; Uicheul Yoon; Dae Lim Koo; Jong-Min Lee; Seung Bong Hong
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

9.  Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Authors:  A Crocker; R A España; M Papadopoulou; C B Saper; J Faraco; T Sakurai; M Honda; E Mignot; T E Scammell
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

10.  Gray matter concentration abnormality in brains of narcolepsy patients.

Authors:  Eun Yeon Joo; Woo Suk Tae; Sung Tae Kim; Seung Bong Hong
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.